StocksFin Logo
JAZZ logo
$JAZZ

Jazz Pharmaceuticals plc

JAZZ country of incorporation
|
https://www.jazzpharma.com
|
Mr. Bruce Cozadd
|
3,200 employees
NASDAQ | Healthcare | Biotechnology
JAZZ reported its Q322 earnings on November 9, 2022 (30 weeks ago).
$940.65M 12.2% vs. Q321 Revenues Q322
85.79% 3.8% vs. Q321 Gross Profit Margin
-2.09% ! 66.9% vs. Q321 Net Profit Margin
422.89M 70.6% vs. Q321 Free Cash Flow Q322
$-0.31 ! 64% vs. Q321 EPS Q322
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 9, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
940.65M
+0.8%
133.66M
-19.65M
-156.7%
$-0.31
Q22022
932.88M
+14.6%
124.21M
34.67M
+2004.7%
$0.56
Q12022
813.72M
115.28M
1.65M
$0.03
FY2021
3.09B
 440.76M
-329.67M
$-5.52
Q42021
896.73M
+7%
136.15M
-35.35M
+33.1%
$-0.57
Q32021
838.12M
+11.5%
145.22M
-52.83M
+85.5%
$-0.86
Q22021
751.81M
+23.7%
119.19M
-363.32M
-398.2%
$-6.11
Q12021
607.58M
40.19M
121.83M
$2.16
FY2020
2.36B
 148.92M
238.62M
$4.28
FY2019
2.16B
 127.93M
523.37M
$9.22
FY2018
1.89B
 121.54M
447.1M
$7.45
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
10.38B
 7.64B
839.36M
5.81B
2.75B
Q22022
11.2B
 8B
711.27M
6.11B
3.2B
Q12022
11.77B
 8.16B
490.84M
6.12B
3.61B
FY2021
12.3B
 8.33B
591.45M
6.2B
3.97B
FY2020
6.54B
 2.88B
1.06B
2.51B
3.66B
FY2019
5.54B
 2.43B
637.34M
1.82B
3.11B
FY2018
5.2B
 2.45B
309.62M
1.63B
2.76B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
417.99M
 4.6M
-289.05M
0
422.89M
+90.8%
Q22022
303.04M
 -89.16M
10.78M
-81.43M
221.61M
+29.1%
Q12022
208.98M
 -37.29M
-270.81M
-37.29M
171.69M
FY2021
778.51M
 -5.21B
3.97B
-45.53M
732.98M
FY2020
899.65M
 -1.01B
528.07M
-379.25M
520.39M
FY2019
776.4M
 -155.3M
-293.75M
-182.34M
594.07M
FY2018
798.9M
 -394.49M
-479.13M
-131.47M
667.43M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees